AtpD is a cornerstone for differentiating Clavibacter subspecies due to its sequence variability and stability. Studies highlight its utility in:
Subspecies Discrimination: MLSA using atpD, alongside gyrB, recA, and rpoB, resolves C. michiganensis subsp. sepedonicus from pathogenic and nonpathogenic relatives .
Population Genetics: Low recombination rates in atpD (r/m ratio = 0.027:1) make it reliable for tracing clonal lineages and global pathogen dispersal .
Recombinant AtpD is synthesized for functional studies and diagnostic tool development. Methods include:
Expression Systems: E. coli-based systems with N-terminal His tags for purification .
Antigenic Potential: Cross-reactivity with antisera against C. michiganensis subsp. michiganensis aids immunoassays but necessitates caution due to false positives .
Pathogenicity Insights: AtpD is not a direct virulence factor but stabilizes ATP synthase in hostile plant environments, enhancing bacterial survival .
Diagnostic Limitations: Cross-reactivity with nonpathogenic Clavibacter-like strains (e.g., C. californiensis) necessitates complementary PCR or MLSA for accurate identification .
Genomic Context: In C. sepedonicus, atpD resides in a stable chromosomal region unaffected by frequent IS element-mediated rearrangements .
KEGG: cms:CMS1924
STRING: 31964.CMS_1924
ATP synthase (Complex V) is a critical enzyme that catalyzes ATP synthesis from ADP and inorganic phosphate using the proton-motive force generated by the substrate-driven electron transfer chain . The beta subunit (atpD) serves as one of the catalytic subunits within the F1 portion of the F1FO ATP synthase complex. Research demonstrates that the beta subunit is essential for proper assembly of the ATP synthase complex, as its absence prevents complex assembly, reduces respiratory rates by approximately 50%, and completely impairs ATP synthesis coupled to respiratory activity . Additionally, the loss of functional ATP synthase affects mitochondrial morphology, particularly the formation of cristae structures .
Clavibacter michiganensis is a Gram-positive phytopathogenic actinobacterium with several subspecies that cause economically significant plant diseases . C. michiganensis subsp. sepedonicus specifically causes bacterial ring rot in potato, a devastating disease that results in significant agricultural losses. Understanding the molecular mechanisms of this pathogen, including its metabolic enzymes like ATP synthase, provides insights into bacterial physiology and potential control strategies. Research on this organism is particularly relevant for developing disease management approaches, as few effective control methods exist beyond chemical treatments such as streptomycin or cupric bactericides .
The atpD gene is one of several housekeeping genes (along with dnaK, gyrB, ppK, recA, and rpoB) commonly used to generate maximum likelihood phylogeny trees for Clavibacter species . As a conserved gene with an appropriate evolutionary rate, atpD provides reliable phylogenetic signals for differentiating between species and subspecies within the Clavibacter genus. For instance, phylogenetic analysis using these genes has helped differentiate the recently identified C. zhangzhiyongii sp. nov. from other Clavibacter species and subspecies . When conducting phylogenetic analysis, researchers typically amplify and sequence a fragment of the atpD gene, align it with homologous sequences from reference strains, and construct phylogenetic trees using appropriate evolutionary models.
Based on current practices in the field, E. coli expression systems are commonly employed for the recombinant production of bacterial ATP synthase subunits, including those from Clavibacter species . When expressing Clavibacter ATP synthase subunits, researchers should consider the following methodological approach:
Vector selection: Vectors containing strong promoters (T7, tac) with appropriate tags (typically His-tags) facilitate expression and subsequent purification .
Expression conditions: Optimization of temperature (typically 16-30°C), IPTG concentration (0.1-1.0 mM), and incubation duration (4-24 hours) to maximize soluble protein yield.
Strain selection: E. coli strains such as BL21(DE3), Rosetta, or Arctic Express are recommended, depending on codon usage and folding requirements.
For membrane proteins like ATP synthase subunits, specialized approaches may be necessary, including the use of mild detergents during extraction and purification processes to maintain protein functionality.
For high-purity recombinant atpD protein preparation, a multi-step purification protocol is recommended:
Initial capture: Immobilized metal affinity chromatography (IMAC) using Ni-NTA or Co-NTA resins for His-tagged proteins, with protein elution using an imidazole gradient (50-500 mM) .
Intermediate purification: Ion exchange chromatography (IEX) based on the theoretical isoelectric point of the atpD protein.
Polishing: Size exclusion chromatography (SEC) for final purification and buffer exchange.
This approach typically yields protein purity greater than 90% as determined by SDS-PAGE . Storage in a Tris/PBS-based buffer with 6% trehalose helps maintain protein stability, and aliquoting is recommended to avoid repeated freeze-thaw cycles which can degrade protein quality .
Verification of recombinant atpD protein should include multiple complementary approaches:
Structural integrity assessment:
Circular dichroism (CD) spectroscopy to evaluate secondary structure
Thermal shift assays to determine protein stability
Limited proteolysis to verify proper folding
Dynamic light scattering (DLS) to assess aggregation state
Functional validation:
ATPase activity assays measuring phosphate release rates
Binding assays with known interaction partners (e.g., other ATP synthase subunits)
Complementation studies in atpD-deficient bacterial strains
| Method | Parameter Measured | Expected Result for Functional atpD |
|---|---|---|
| ATPase assay | Phosphate release | >1 μmol Pi/min/mg protein |
| Thermal shift | Melting temperature (Tm) | 45-65°C (depends on species) |
| CD spectroscopy | Alpha-helix content | ~30-40% for properly folded protein |
| SEC-MALS | Oligomeric state | Primarily hexameric assembly |
The atpD gene provides an excellent target for developing molecular diagnostic tools due to its sequence conservation within the species but sufficient variation between closely related species. A methodological approach includes:
Primer design: Design specific primers targeting unique regions of the atpD sequence in C. michiganensis subsp. sepedonicus. Multiple sequence alignment with atpD sequences from related Clavibacter species should be performed to identify subspecies-specific regions.
PCR optimization: Develop and validate qPCR or LAMP (Loop-mediated isothermal amplification) assays targeting the atpD gene. Parameters to optimize include:
Annealing temperature (typically 55-62°C)
Magnesium concentration (1.5-3.0 mM)
Primer concentration (0.2-0.5 μM)
Cycle parameters
Validation strategy:
Analytical sensitivity (limit of detection: ideally <100 copies)
Analytical specificity (no cross-reaction with near neighbors)
Robustness (performance across different sample matrices)
This approach leverages the atpD gene's phylogenetic utility to create reliable diagnostic tools for pathogen detection in agricultural settings.
Multiple sequence alignment of atpD sequences from diverse bacterial species, including:
Plant pathogens (various Clavibacter subspecies)
Animal pathogens
Environmental bacteria
Structure prediction and comparative modeling:
Homology modeling based on available ATP synthase crystal structures
Identification of subspecies-specific structural features
Analysis of catalytic site conservation and variation
Functional domain analysis:
Catalytic site residues (typically highly conserved)
Nucleotide-binding regions
Interfaces with other ATP synthase subunits
While the complete atpD sequence for C. michiganensis subsp. sepedonicus is not provided in the search results, related proteins from the same genus provide insight. For instance, the ATP synthase subunit c (atpE) from C. michiganensis subsp. sepedonicus consists of 77 amino acids , and likely functions as part of the proton-translocating component of the ATP synthase complex.
A robust experimental design for studying atpD gene function through knockout or inhibition should include the following controls:
Genetic manipulation controls:
Wild-type strain (positive control for normal phenotype)
Complemented mutant (reintroduction of functional atpD to verify phenotype restoration)
Unrelated gene knockout (to control for general effects of genetic manipulation)
Phenotypic analysis controls:
Growth curve comparison in different media (rich vs. minimal)
ATP measurements under varying energy demands
Respiratory capacity measurements with different substrates
Environmental condition variations:
Standard growth temperatures vs. stress temperatures
Normal pH vs. acidic/alkaline conditions
Presence/absence of oxidative stress
Research on ATP synthase beta subunit function in C. reinhardtii demonstrates that absence of this subunit prevents complex assembly, reduces respiratory rate by 50%, eliminates coupled ATP synthesis, and affects mitochondrial morphology . Similar comprehensive phenotypic analyses should be conducted for Clavibacter atpD studies.
Expression and purification of membrane-associated ATP synthase components present several challenges:
Solubility issues:
Challenge: ATP synthase subunits may form inclusion bodies during expression
Solution: Use lower expression temperatures (16-20°C), specialized E. coli strains (C41/C43), or fusion partners (MBP, SUMO)
Maintaining native conformation:
Challenge: Detergent selection can affect protein structure and function
Solution: Screen multiple detergents (DDM, LMNG, CHAPS) and lipid additives
Functional complex assembly:
Challenge: Individual subunits may not fold properly without partners
Solution: Co-expression strategies for interacting subunits
| Methodological Challenge | Recommended Approach | Expected Outcome |
|---|---|---|
| Inclusion body formation | Expression at 18°C with 0.1-0.2 mM IPTG | Increased soluble protein yield |
| Detergent optimization | Sequential screening with DDM, LMNG, and amphipols | Identification of conditions maintaining native structure |
| Complex assembly analysis | Blue native PAGE with samples prepared in different detergents | Verification of proper oligomeric assemblies |
| Activity preservation | Reconstitution in liposomes or nanodiscs | Restoration of activity closer to native levels |
Distinguishing primary effects from adaptive responses requires careful experimental design:
Temporal analysis:
Immediate vs. delayed responses to atpD disruption
Time-course experiments tracking changes in gene expression, metabolism, and phenotype
Metabolic flux analysis:
Use of isotope-labeled substrates to track metabolic pathway shifts
Quantification of key metabolites in central metabolism
Multi-omics integration:
Transcriptomics to identify compensatory gene expression
Proteomics to detect changes in protein levels and post-translational modifications
Metabolomics to characterize metabolic reconfigurations
Genetic approach:
Construction of double mutants blocking potential compensatory pathways
Inducible gene expression systems for controlled atpD depletion
Research on ATP synthase disruption in other organisms indicates that direct effects (reduced ATP levels, increased proton gradient) occur rapidly, while adaptive responses (altered metabolism, growth rate adjustments) develop over longer timeframes .
Structural studies of Clavibacter ATP synthase could reveal unique features that differentiate it from host ATP synthases, enabling the development of selective inhibitors. A methodological roadmap includes:
High-resolution structure determination:
Cryo-electron microscopy of the intact ATP synthase complex
X-ray crystallography of individual subunits, particularly atpD
NMR studies of dynamic regions and ligand interactions
Structure-based drug design:
Identification of binding pockets unique to Clavibacter ATP synthase
Virtual screening of compound libraries against these pockets
Fragment-based approaches to develop novel inhibitor scaffolds
Rational design of species-selective inhibitors:
Targeting regions that differ between Clavibacter and host organisms
Development of covalent inhibitors for specific cysteine residues
Allosteric inhibitors targeting non-catalytic regions
Validation pipeline:
In vitro enzymatic assays with purified components
Cell-based assays measuring bacterial growth inhibition
Specificity testing against host ATP synthases
While the search results don't directly address atpD mutations in antimicrobial resistance for Clavibacter, they do highlight that this genus can develop resistance through various mechanisms . A comprehensive research approach would include:
Surveillance studies:
Sequencing atpD from field isolates with varying antimicrobial susceptibility
Correlation of sequence variations with resistance phenotypes
Experimental evolution:
Serial passage of Clavibacter in sublethal concentrations of antimicrobials
Whole genome sequencing to identify adaptive mutations
Functional validation:
Site-directed mutagenesis to introduce suspected resistance mutations
Phenotypic characterization of engineered strains
Research on streptomycin resistance in C. michiganensis demonstrates that resistance can arise through different mechanisms, including target site mutations and potentially novel mechanisms independent of previously described loci . Similar diversity might exist for adaptations affecting ATP synthase function.
Systems biology offers powerful approaches to understand atpD function in the context of whole-cell metabolism:
Genome-scale metabolic modeling:
Construction of a constraint-based metabolic model for C. michiganensis subsp. sepedonicus
Flux balance analysis to predict metabolic reconfiguration in response to atpD perturbation
Identification of essential reactions and potential synthetic lethal interactions
Network analysis:
Protein-protein interaction mapping focused on ATP synthase components
Regulatory network reconstruction to identify factors controlling atpD expression
Metabolic network analysis to identify energy-dependent pathways
Multi-omics data integration:
Correlation of transcriptomic, proteomic, and metabolomic data sets
Machine learning approaches to identify patterns associated with ATP synthase dysfunction
Causal network inference to distinguish direct from indirect effects
Comparative systems analysis:
Cross-species comparison of ATP synthase integration within bacterial metabolic networks
Identification of conserved vs. species-specific regulatory mechanisms